Sage Journals: Discover world-class research

Abstract

The primary objectives of this work were: (1) to describe trends in HIV prevalence among those undergoing carotid intervention (carotid endarterectomy or carotid artery stenting) in the United States; and (2) to determine if HIV infection is independently associated with symptomatic carotid atherosclerotic disease or age at the time of carotid intervention. In a nationally representative inpatient database from 2004 to 2014, HIV infection was associated with younger age at the time of carotid intervention (59 years [SE 0.2] vs 71 years [SE 0.01], p < 0.001), male sex (83% vs 58%, p < 0.001), black race (21% vs 4%, p < 0.001), and symptomatic carotid atherosclerotic disease (18.8% vs 11.0%, p < 0.001). Among those undergoing carotid intervention, there was a significant increase in the prevalence of HIV from 0.08% in 2004 to 0.17% in 2014 (p < 0.001). After adjustment for patient demographics, comorbidities and other covariates, HIV infection remained significantly associated with younger age (–8.9 years; 95% CI: –9.7 to −8.1; p < 0.001) at the time of carotid intervention, but HIV infection was not independently associated with symptomatic carotid atherosclerotic disease.

Keywords

HIV atherosclerosis carotid artery disease endarterectomy epidemiology population health stent

Get full access to this article

View all access options for this article.

References

Gutierrez

Albuquerque

ALA

Falzon

HIV infection as vascular risk: A systematic review of the literature and meta-analysis. PLoS One 2017; 12: e0176686.

Feinstein

Bahiru

Achenbach

et al . Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013. Am J Cardiol 2016; 117: 214–220.

Mdodo

Frazier

Dube

et al . Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: Cross-sectional surveys. Ann Intern Med 2015; 162: 335–344.

Triant

Lee

Hadigan

et al . Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92: 2506–2512.

Seaberg

Muñoz

et al . Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005; 19: 953–960.

Brown

Cole

et al . Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005; 165: 1179–1184.

De Gaetano Donati

Rabagliati

Iacoviello

et al . HIV infection, HAART, and endothelial adhesion molecules: Current perspectives. Lancet Infect Dis 2004; 4: 213–222.

Kearns

Gordon

Burdo

et al . HIV-1—Associated atherosclerosis. J Am Coll Cardiol 2017; 69: 3084–3098.

Nou

Grinspoon

SK.

Inflammation, immune activation, and cardiovascular disease in HIV. AIDS 2016; 30: 1495–1509.

10.

Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality (AHRQ). HCUP National Inpatient Sample (NIS), 2012, 2013, 2014, www.hcup-us.ahrq.gov/nisoverview.jsp (2018 accessed 5 February 2018).

11.

Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality (AHRQ). HCUP Nationwide Inpatient Sample (NIS), 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, www.hcup-us.ahrq.gov/nisoverview.jsp (accessed 5 February 2018).

12.

Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality (AHRQ). List of HCUP data partners for reference in publications, https://www.hcup-us.ahrq.gov/db/hcupdatapartners.jsp (2018, accessed 5 February 2018).

13.

Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality (AHRQ). Trend weights for HCUP NIS data, www.hcup-us.ahrq.gov/db/nation/nis/trendwghts.jsp (2015, accessed 5 February 2018).

14.

Elixhauser

Steiner

Harris

et al . Comorbidity measures for use with administrative data. Med Care 1998; 36: 8–27.

15.

Quan

Sundararajan

Halfon

et al . Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130–1139.

16.

Van Walraven

Austin

Jennings

et al . A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009; 47: 626–633.

17.

R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, https://www.r-project.org/ (2017, accessed 5 February 2018).

18.

Van Buuren

Groothuis-oudshoorn

Robitzsch

et al . mice: Multivariate imputation by chained equations in R. J Stat Softw 2011; 45: 1–67.

19.

Smilowitz

Gupta

Guo

et al . Influence of human immunodeficiency virus seropositive status on the in-hospital management and outcomes of patients presenting with acute myocardial infarction. J Invasive Cardiol 2016; 28: 403–409.

20.

Periard

Cavassini

Taffe

et al . High prevalence of peripheral arterial disease in HIV-infected persons. Clin Infect Dis 2008; 46: 761–767.

21.

Hsue

Franklin

et al . Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004; 109: 1603–1608.

22.

Hanna

Post

Deal

et al . HIV infection is associated with progression of subclinical carotid atherosclerosis. Clin Infect Dis 2015; 61: 640–650.

23.

Chow

Price

Hsue

et al . Greater risk of stroke of undetermined etiology in a contemporary HIV-infected cohort compared with uninfected individuals. J Stroke Cerebrovasc Dis 2017; 26: 1154–1160.

24.

Hess

Johnson

et al . Diagnoses of HIV infection in the United States and dependent areas, 2016. HIV Surveill Rep; 2 (accessed 10 January 2018).

25.

Trickey

May

Vehreschild

J-J

et al.; Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. Lancet HIV 2017; 4: e349–e356.

26.

Wong

Gange

Moore

et al . Multimorbidity among persons living with human immunodeficiency virus in the United States. Clin Infect Dis 2018; 66: 1230–1238.

27.

Luebke

Brunkwall

Impact of real-world adherence with best medical treatment on cost-effectiveness of carotid endarterectomy for asymptomatic carotid artery stenosis. Ann Vasc Surg 2016; 30: 236–247.

28.

Ovbiagele

Nath

Increasing incidence of ischemic stroke in patients with HIV infection. Neurology 2011; 76: 444–450.

29.

Chow

Regan

Feske

et al . Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr 2012; 60: 351–358.

30.

Tipping

de Villiers

Wainwright

et al . Stroke in patients with human immunodeficiency virus infection. J Neurol Neurosurg Psychiatry 2007; 78: 1320–1324.

31.

Phan

BAP

Weigel

et al . Utility of 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines in HIV-infected adults with carotid atherosclerosis. Circ Cardiovasc Imaging 2017; 10: e005995.

32.

Mateen

Post

Sacktor

et al . Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men. Neurology 2013; 81: 2094–2102.

33.

Jonas

Feltner

Amick

et al . Screening for asymptomatic carotid artery stenosis: A systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2014; 161: 336–346.

34.

León

Reus

López

Subclinical atherosclerosis in low Framingham risk HIV patients. Eur J Clin Invest 2017; 47: 591–599.

35.

Janjua

Staziaki

Szilveszter

et al . Presence, characteristics, and prognostic associations of carotid plaque among people living with HIV. Circ Cardiovasc Imaging 2017; 10: e005777.

36.

Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality (AHRQ). Introduction to the HCUP National Inpatient Sample (NIS), https://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2014.jsp (2014, accessed 21 February 2018).

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.09 MB